Request Deal Involvement
Angelini Pharma to acquire Arvelle Therapeutics for $960m.
Identify your role
Select the side you represented in this transaction, and provide your current job title.
Service Providers
legal advisors
Sidley Austin
financial advisors
Centerview Partners
legal advisors
NautaDutilh
pr advisors
Consilium Strategic Communications
legal advisors
White & Case
accounting advisors
KPMG
tax advisors
KPMG
pr advisors
Deekeling Arndt Advisors in Communications
pr advisors
Havas
or
Principals
target
ARVELLE THERAPEUTICS
bidder
ANGELINI THERAPEUTICS
vendor
SK BIOPHARMACEUTICALS
vendor
BRV CAPITAL MANAGEMENT
vendor
KB INVESTMENT
vendor
LIFE SCIENCES PARTNERS
vendor
ANDERA PARTNERS
vendor
NOVAQUEST CAPITAL
vendor
F-PRIME CAPITAL
vendor
HIG BIOVENTURES
Principals or Service Provider not listed?Add missing Service Provider or Principal
Enter your Job Title on this deal
This title will appear on your profile next to this deal involvement.
To help us verify your involvement, please include links to any relevant publications that mention you or your company's role in this deal:
All rights reserved. Copyright © 2025 Datasite